Safety and Efficacy Study of BCD-066 Compared to Aranesp® for Anemia Treatment in Chronic Kidney Disease Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of the study is to prove equivalence of efficacy and safety of BCD-066 and Aranesp® in treatment of anemia in end-stage chronic kidney disease patients on dialysis.
Epistemonikos ID: 4d7e8b4b25bf126f7a771422d22080c99c09cde8
First added on: May 12, 2024